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Abstract. – Endometriosis is a common, be-
nign, estrogen-dependent gynecological dis-
ease that represents one of the main causes of
hospitalization in industrialized countries. It is
well established that a large amount of natural
and man-made chemicals are present in the en-
vironment and both humans and animals are
exposed to them. Dioxin and dioxin-like com-
pounds have long biological half-life, can accu-
mulate within the organism and could negative-
ly affect several physiological processes. The
purpose of this review is to provide an
overview of the possible relationship between
these chemicals and the pathogenesis of en-
dometriosis.
Key Words:
Endometriosis, Environment, Dioxin, Dioxin-like
compounds.
Introduction
It is well established that a large amount of
natural and man-made chemicals are present in
the environment and both humans and animals
are exposed to them. Due to their long biological
half-life, these toxicants accumulate within the
organism and could negatively affect several
physiological processes. In 2005 the Enviromen-
tal Working Group tested for chemicals and pol-
lutants the umbilical cord blood, collected after
the cut, of 10 babies born between August and
September 2014. 287 different chemicals were
detected: 217 of them are toxic to the brain and
nervous system, 180 could play a significant role
in cancer development and 208 negatively impact
the developing fetus leading to birth defects. The
astonishing result was that although not every
child has been exposed to every toxicant detect-
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ed, no child was exposed to no pollutants1. Sever-
al toxicants have individually been related to
neoplasm development, reproductive dysfunc-
tions, immunological and thyroid disorders2. It is
difficult to determine the combinatorial effect of
these agents because numerous chemicals act
synergistically in disease processes, but an antag-
onistic effect it is also possible3,4. Timing of toxic
compound exposure seems to be crucial in defin-
ing an individual’s risk of disease. The knowl-
edge of the mechanism of action of each chemi-
cal on organ systems at each stage of life is fun-
damental to assess the exact risk. Among numer-
ous toxic agents identified in the human umbili-
cal cord, 2,3,7,8-tetrachlorodibenzo-p-dioxin
(TCDD) is the most studied because it is consid-
ered the most toxic compound ever produced.
Nonetheless, some other chemicals such as poly-
chlorinated biphenyls (PCBs) and polychlorinat-
ed dibenzofurans (PCDFs) showed a similar toxi-
city, due to their similar chemical structure5. The
purpose of this review is to provide an overview
of the possible relationship between these envi-
ronmental toxicants and endometriosis.
Endometriosis
Endometriosis is a common, benign, estrogen-
dependent gynecological disease that represents
one of the main causes of hospitalization in in-
dustrialized countries6. It involves 5%-15% of re-
productive age women and it estimated that al-
most 7 million women in the USA are affected7.
Endometriosis has a huge economical burden, re-
lated to its debilitating nature that leads to high
care costs and loss of productivity8. Endometrio-
sis is described by pathologists as the presence of
stromal and/or endometrial glandular epithelium
implants outside the uterine cavity9. It commonly
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involves ovaries, uterosacral ligaments, peri-
toneum, rectocervical and rectovaginal area, ap-
pendix, bladder and ureters and sometimes could
spread even beyond the pelvis6,10,11.
At the present time major interest has been
shown in the so called deep infiltrating en-
dometriosis (DIE), which represent a severe form
of the disease where ectopic endometrial glands
end stroma penetrate > 5 mm under the peri-
toneal surface of different pelvic organs12.
Regarding the symptoms some patients are
completely asymptomatic, but most of them re-
port pelvic pain, dysmenorrhea, dyspareunia,
dyschezia and urinary symptoms during the
menses.
Although endometriosis represents a leading
cause of disability its exact etiopathogenenesis is
still under debate and many aspects of the dis-
ease are under targets. Two main hypotheses
have been taken into consideration in the last
decades:
• the retrograde menstruation theory presuppos-
es that menstrual blood containing endometrial
cells flows back through the Fallopian tubes
and into the pelvic cavity where for some rea-
sons it would not be clear out by the immune
system cells;
• the coelomic metaplasia theory postulates that
endometriosis originates from the metaplasia
of the mesothelium of the visceral and abdom-
inal peritoneum.
Since the 90s, several studies have investigated
possible immunological dysfuncions potentially
related to endometriosis, with the main mecha-
nism presumed to be additional to the retrograde
menstruation theory13. The cells falling into the
abdominal cavity should be identified as antigens
and presented by macrophages to T cells through
the major histocompatibility complex (MHC)
class I or class II. Class I MHC activates cytotox-
ic T cells and class II MHC activates helper T
cells, leading to target-cell death14. Any alteration
of these processes could be involved in the
pathogenesis of endometriosis.
Dioxin and Dioxin-Like Compounds
Dioxins and dioxin-like compounds are ex-
tremely resistant by-products of various industri-
al processes (e.g. waste incineration, iron/steel
industries) and represent ubiquitous environmen-
tal pollutants, chemically stable and lipid soluble.
Dioxins are polycyclic aromatic agents with
chloral substituents. Based on the position of the
chlorine atoms they are classified in different
branches. Dioxins and dioxin-like compounds in-
clude:
• polychlorinated dibenzo-p-dioxins (PCDDs or
dioxins): there are 75 PCDDs, 7 of them are
highly toxic
• polychlorinated dibenzofurans (PCDFs): there
are 135 PCDFs. They are not dioxins, but 10
of them have dioxin-like properties
• polychlorinated biphenyls (PCBs): there are
209 PCBs, 12 of them have dioxin-like proper-
ties (the so called coplanar PCBs because of
the absence of chlorine substitution in ortho
positions that gives the molecule a planar con-
figuration). There have been widely used as di-
electric and coolant fluids until they were
banned worldwide in the 80s.
PCDDs, PCDFs and PCBs together form the
group of polyhalogenated hydrocarbons and in
recent studies were found to be significantly as-
sociated with endometriosis15-17.
Dioxin generally enters the environment after
accidents like the one in Seveso, Italy in 1976.
Dioxins then get into soil sediments, being car-
ried by weather patterns and become incorporat-
ed into the food chain18,19. They mainly enter the
human body through food and, due to their
lipophilic nature, accumulate in tissues with high
fat content20. Because of this property, it does not
surprise to find high levels of dioxin and dioxin-
like compounds in older people and reduced lev-
els after delivery or breastfeeding21. 10 PCDFs
and 12 PCBs (those with dioxin-like properties)
and 7 PCDDs bind to the aryl hydrocarbon re-
ceptor (AhR), an activated ligand transcription
factor. AhR could be mostly found in the cytosol
(sometimes in the nucleus) and represents the
key component of the dioxin pathways22. In order
to quantify their biological potency all dioxin-
like compounds have received a toxic equivalen-
cy factor (TEF) in terms of the most toxic dioxin
(TCDD), which has a TEF of 1. However, the
toxicity of a mixture of these compound is often
expressed in pg TEQ (toxic equivalent units)/g
lipids, which represents the sum of the product of
the concentration of each compound multiplied
by its TEF. The concentration is expressed per g
lipids because they are mainly stored in adipose
tissue23.
Mechanism of Action
Dioxin and dioxin-like molecules can pass the
plasma membrane and when in cytoplasm can
bind to the AhR. The AhR then reach the nucleus
and bind to its AhR nuclear translocator (ARNT)
forming a heterodimer that activates genes with
xenobiotic response elements (XREs)/dioxin re-
sponse elements (DREs) at their regulatory site23.
The major targets are elements of the detoxifica-
tion system24, but AhR could also activate factors
normally involved in cell proliferation such as
transforming growth factor-beta (TGFβ) and cy-
tokines, leading to deregulated physiologic func-
tions25. There is a high concentration of AhR in
both endometrium and immune cells. Exposure
to TCDD promotes the production of matrix met-
alloproteinases (MMPs) in endometrial tissue,
even in the presence of normal concentration of
progesterone, a hormone that typically abolishes
their secretion26. In fact during the secretory
phase of the menstrual cycle progesterone down-
regulates endometrial MMPs, making that the ex-
foliation of the endometrium does not occur be-
fore menstruation. In 2008, Bruner-Tran et al27
found that these chemicals are able to activate an
inflammatory-like pathway that reduces the abili-
ty of progesterone to suppress MMPs expression
in both stromal and epithelial cells. In addition to
that a direct crosstalk between dioxins/AHR
complex and the estrogen receptor-α (ER-α) has
been found28. Considered that upon ligand bind-
ing the receptor undergoes an affinity-dependent
conformational change, it could result in an im-
proper transcriptional process of ER targets, such
as the progesterone receptor. Furthermore, is well
known that reduced levels of natural killer (NK)
cell cytotoxicity and alterations in peripheral
blood monocytes and peritoneal macrophages
characterize women affected by endometrio-
sis29,30. Although more work needs to be done, it
is plausible that inflammatory-like processes,
caused by dioxin-like environmental chemicals,
can alter normal endometrial and immune cell
physiology allowing persistence and develop-
ment of endometrial tissue within the peritoneal
cavity, normally cleared by immune system cells.
Dioxins/Dioxin-like Compounds and
Endometriosis
The first study to report a possible association
between dioxins and endometriosis was the one
published by Rier et al31 in 1993, although it was
not directly designed to investigate the disease.
They found that Rhesus Monkeys previously ex-
posed to TCDD (5 and 25 ppt per day during 4
years) developed a dose-related form of en-
dometriosis. Some years later Rier et al32 reevalu-
ated their work and reported significant amounts
of dioxin-like PCBs in the blood samples, indi-
cating a possible co-exposure. After this study an
increasing interest came up in regard to the role
of dioxins and dioxin-like environmental chemi-
cals in the pathogenesis of endometriosis. Al-
though in the last decade several epidemiologic
surveys have been published this relationship re-
mains controversial (Table I).
In fact, the study conducted by Eskenazi et al33
failed to demonstrate an increase incidence of en-
dometriosis in women living in Seveso, Italy dur-
ing a 1976 factory explosion. This was 20-year
follow up study, which examined women who
were 30 years old in 1976. A doubled but not sig-
nificant risk of endometriosis was found in
women who had ≥100 ppt TCDD in their serum.
The authors concluded that a disease misclassifi-
cation could have led to underestimate the risk.
The selection of the control group is a possible
source of error in an epidemiological study. For
example, Heiler et al16 demonstrated that women
with deep endometriotic nodules have significant
higher levels of PCDDs/PCDFs/PCBs when
compared to controls and a slight elevation was
found in patients with peritoneal endometriosis
when compared to controls. However, Tsukino et
al34 found no statistical differences between case
and control group, including in the control group
both infertile women and patients with stage I
endometriosis while Heiler at al15,16 considered
only healthy women. These differences in popu-
lation selection could explain the different results
obtained. Furthermore, women living in the same
area should be recruited as both cases as con-
trols, so that both groups have been similarly ex-
posed to toxicants. Another confounding source
could be the development of endometriosis as co-
morbidity factor in infertile women. Dioxin-like
compound could be associated to altered devel-
opment of reproductive tract dysfunctions and
could independently affect fertility. Thus, using
infertile patients as controls can lead to a confus-
ing interpretation of the results34,35. Another po-
tential source of error is the method used to ex-
clude the presence of endometriosis in the con-
trol group. Laparoscopy followed by histological
confirmation remains the only reliable diagnostic
tool for assessing the presence or absence of the
disease.
In 2009 Porpora et al36 found a significant as-
sociation between selected PCB congeners and
endometriosis, but the total TEQ was not in-
creased, underlining that the different congeners
examined could influence the results. In fact,
most of the toxicants have limited activity and
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the total TEQ could not correlate with the dis-
ease, since they could restrict the activity of more
potent chemicals. In most of the studies exam-
ined, the concentration of selected toxicants was
measured in serum samples, not considering the
effect of fasting. As a matter of fact, there is a
significant difference in mean toxicant concen-
tration between fasting and nonfasting
samples37. In order to obtain a meaningful com-
parison between studies a standardized collec-
tion procedure or a correction for total serum fat
is required. Additionally, breastfeeding is an im-
portant route of PCBs excretion, which leads to
a significant reduction in the body burden of
dioxin-like compounds. To avoid the confound-
ing factor of breastfeeding, only nulliparous
women or who have never breastfed should be
enrolled. Also the type of endometriosis can af-
fect the results. Heilier et al15,16 found that con-
centrations of PCBs and dioxin-like compounds
in serum were associated with a significantly in-
creased risk of developing nodules of the recto-
vaginal septum, while the risk of developing
peritoneal endometriosis was not statistically
significant. Although, there is no clear agree-
ment on the definition of endometriosis and deep
infiltrating endometriosis seems to have a differ-
ent disease process and including it in the same
group of patients affected by peritoneal en-
dometriosis may not be opportune. In a recent
case-control study published by Martínez-Zamo-
ra et al38 only patients with deep infiltrating en-
dometriosis were enrolled and a significant high-
er TEQ and concentration of dioxins and PCBs
were found in omental adipose tissue, suggest-
ing a potential role of these chemicals in the de-
velopment of the disease. Despite this, a main
limitation of this study was the small sample
size. Genetic and environmental factors may
contribute to the onset and progression of en-
dometriosis. The presence of mutations in genes
responsible for the detoxification such as glu-
tathione transferase (GST), alone or in combina-
tion with exposure to PCBs was analyzed. Vichi
et al39 demonstrated that GST polymorphisms
per se do not increase the risk of developing en-
dometriosis. However, a gene-environment inter-
action was observed for GSTP1 and GSTM1
null genotypes modulating the effect of PCBs.
Given the increased sensibility of fetuses and in-
fants, studies aimed to assess whether the expo-
sure in utero, in childhood and during puberty
may increase the risk of developing endometrio-
sis in adulthood are underway.
Conclusions
The conflicting results obtained could be the
consequence of small sample size, different se-
lection of the controls, different methods of as-
sessment for toxicants, different types of con-
geners tested and different statistical tests used,
but a link between dioxins and dioxin-like chem-
icals seems to be plausible. However, the exact
mechanism through which they operate is not
clear, yet. They could interfere with both immune
and endocrine systems. Further studies in this
field are needed in order to promote prevention
strategies.
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